Jasper Therapeutics Ownership | Who Owns Jasper Therapeutics?

Jasper Therapeutics Ownership Summary

Jasper Therapeutics is owned by 107.28% institutional investors, 1.28% insiders. Polar Capital Healthcare Opports Inc is the top mutual fund, with 3.85% of its assets in Jasper Therapeutics shares.

JSPR Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Jasper Therapeutics	107.28%	1.28%	-8.55%
Sector	Healthcare Stocks	57.39%	9.93%	32.68%
Industry	Biotech Stocks	68.48%	9.65%	21.87%

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2024	92	10.84%	15,645,934	6.60%	107	1.12%	51	15.91%	17	-10.53%
Sep 30, 2024	83	18.57%	14,676,954	0.82%	97	1.04%	44	-	19	111.11%
Jun 30, 2024	70	9.38%	14,557,013	11.80%	97	1.02%	44	25.71%	9	-62.50%
Mar 31, 2024	64	64.10%	13,020,873	-82.64%	97	2.12%	35	105.88%	24	166.67%
Dec 31, 2023	39	-7.14%	74,996,253	-18.08%	68	0.97%	17	-	9	28.57%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Polar Capital Healthcare Opports Inc	581.54K	3.85%	-
T. Rowe Price Small-Cap Value	438.98K	2.92%	-
Vanguard Total Stock Mkt Idx Inv	401.22K	2.67%	-
Franklin Biotechnology Discv A(acc)USD	339.25K	2.26%	-
iShares Russell 2000 ETF	302.48K	2.01%	-2.64K
HBM Healthcare Investments AG Ord	250.00K	1.67%	-
Fidelity Select Health Care	208.04K	1.39%	208.04K
Franklin Biotechnology Discovery A	195.44K	1.30%	-
Vanguard Institutional Extnd Mkt Idx Tr	183.94K	1.22%	-
DWS ESG Biotech LC	160.00K	1.07%	1.00

Recent Insider Transactions

Date	Name	Role	Activity	Value
Dec 12, 2024	Mahal Jeetinder Singh	Chief Operating Officer	Sell	$19.90K
Sep 12, 2024	Mahal Jeetinder Singh	Chief Operating Officer	Sell	$19.10K
Jun 12, 2024	Mahal Jeetinder Singh	Chief Operating Officer	Sell	$21.74K
Mar 12, 2024	Mahal Jeetinder Singh	Chief Operating Officer	Sell	$23.79K
Feb 08, 2024	Carlyle Group Inc.	Former 10% Owner	Buy	$2.46M

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	-	1
2024 Q3	-	1
2024 Q2	-	1
2024 Q1	2	1
2023 Q4	5	1

JSPR Ownership FAQ

Who Owns Jasper Therapeutics?

Jasper Therapeutics shareholders are primarily institutional investors at 107.28%, followed by 1.28% insiders and -8.56% retail investors. The average institutional ownership in Jasper Therapeutics's industry, Biotech Stocks , is 68.48%, which Jasper Therapeutics exceeds.

Does Blackrock own Jasper Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Jasper Therapeutics.

Who is the top mutual fund holder of Jasper Therapeutics shares?

Polar Capital Healthcare Opports Inc is the top mutual fund holder of Jasper Therapeutics shares, with 3.85% of its total shares outstanding invested in 581.54K Jasper Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools